N/A
N=327
Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3
Drug Use Disorders · Hepatitis C · Harm Reduction · Opioid-use Disorder
Bottom Line
View on ClinicalTrials.gov: NCT04268173 ↗Enrolled (actual)
327
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale — 1.26; 1.07; 1.12; 1.03 score on a scale — p=0.84
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Community-Based, Client-Centered Prevention Home (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Wisconsin, Madison
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale |
1.26; 1.07; 1.12; 1.03 | 0.84 |
| PRIMARY Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Frequency of "Yes" Answers |
0.17; 0.16; 0.037; 0.11 | — |
| PRIMARY Change in the Risk of HIV as Assessed by Change in Likert Scale |
1.05; 1.09; 1.28; 0.86 | — |
| PRIMARY Change in the Risk of HIV as Assessed by Risky Behavior Frequencies |
0.24; 0.25; 0.19; 0.21 | — |
| PRIMARY Change in the Risk of Drug Overdose as Assessed by Change in Likert Scale |
0.52; 0.42; 0.57; 0.56 | — |
Summary
The goal of this study was to effectively use a client-centered community-based intervention to engage people who inject drugs (PWIDs) in healthcare that helps reduce risky behaviors and lower infectious disease risks. Participants in the intervention group of this study received a 12-week intensive multilevel harm reduction case-management intervention at three rural Vivent Health offices. Service coordination aimed to reduce human immunodeficiency virus (HIV), hepatitis C virus (HCV), and overdose risks in PWIDs. Prevention Navigators (PNs) at each office helped to coordinate referrals to reduce substance use disorder and increase engagement in the substance use disorder care cascades.
Eligibility Criteria
Inclusion Criteria
- has injected drugs in the past 30 days, resides in Wisconsin, over 18 years of age
- able to read and write in English
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT04268173). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.